Page last updated: 2024-08-24
vamicamide and Hepatitis C, Chronic
vamicamide has been researched along with Hepatitis C, Chronic in 1 studies
*Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. [MeSH]
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Boujenah, JL; Bourlière, M; Cadranel, JF; Fontanges, T; Ouzan, D; Pol, S; Trepo, C | 1 |
Other Studies
1 other study(ies) available for vamicamide and Hepatitis C, Chronic
| Article | Year |
|---|---|
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Polyethylene Glycols; Prospective Studies; Pyridines; Recombinant Proteins; Self Administration; Surveys and Questionnaires | 2007 |